Keywords: genta, g3139, moves, into, ph, iii, melanoma

Genta's G3139 moves into Ph III for melanoma

Article | 21 July 2000

Print This

US Oncology, a company which represents health care professionals inthe cancer field, has initiated a pivotal trial of Genta's G3139, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in